Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective AnalysisYang You, Yuhong Zhou, Xi Guo et al.|Frontiers in Molecular Biosciences|2021Cited by 35
Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcomaWenshuai Liu, Yuhong Zhou, Hanxing Tong et al.|BMC Cancer|2020Cited by 17
<p>Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing</p>Chenlu Zhang, Yuhong Zhou, Zhiming Wang et al.|OncoTargets and Therapy|2020Cited by 15
Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case reportJing Wu, Qian Li, Qi Zhang et al.|Annals of Translational Medicine|2022Cited by 7
Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTENXi Guo, Yuhong Zhou, Suyao Li et al.|Frontiers in Oncology|2022Cited by 6